Torrent Pharmaceuticals
Torrent Pharmaceuticals Limited, commonly known as Torrent Pharma, is a prominent player in the global pharmaceutical industry, headquartered in Ahmedabad, India. Founded in 1959, the company has established a strong presence in various operational regions, including North America, Europe, and emerging markets across Asia and Africa. Specialising in the development, manufacturing, and marketing of a diverse range of generic and branded pharmaceuticals, Torrent Pharma focuses on therapeutic areas such as cardiovascular, central nervous system, and anti-infectives. The company is recognised for its commitment to quality and innovation, which has led to significant milestones, including a robust portfolio of over 200 products. With a strong market position, Torrent Pharmaceuticals has garnered accolades for its research and development capabilities, making it a trusted name in the industry. Its dedication to improving patient outcomes through affordable healthcare solutions sets it apart in a competitive landscape.
DitchCarbon Score
How does Torrent Pharmaceuticals's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Medical Device Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Torrent Pharmaceuticals's score of 32 is higher than 87% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Torrent Pharmaceuticals's reported carbon emissions
In 2024, Torrent Pharmaceuticals reported total carbon emissions of approximately 91562000 kg CO2e, comprising about 15294000 kg CO2e from Scope 1 and about 76268000 kg CO2e from Scope 2 emissions. This marks a significant reduction in emissions intensity, with a Scope 1 and 2 emissions factor of about 0.0711 kg CO2e per rupee of turnover, reflecting their commitment to improving operational efficiency. In 2023, the company recorded total emissions of around 102174000 kg CO2e, with Scope 1 emissions at about 25063000 kg CO2e and Scope 2 emissions at approximately 97111000 kg CO2e. This indicates a continued focus on reducing their carbon footprint. For 2022, Torrent Pharmaceuticals reported total emissions of about 126926000 kg CO2e, with Scope 1 emissions of approximately 28009000 kg CO2e and Scope 2 emissions of about 98916000 kg CO2e. The emissions per rupee of turnover remained consistent at about 0.0019 kg CO2e. Despite these figures, there are currently no publicly disclosed reduction targets or climate pledges from Torrent Pharmaceuticals. The company is actively working within the pharmaceutical industry context, which is increasingly prioritising sustainability and carbon reduction initiatives.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
| 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|
| Scope 1 | 28,072,000 | 00,000,000 | 00,000,000 | 00,000,000 |
| Scope 2 | 96,026,000 | 00,000,000 | 00,000,000 | 00,000,000 |
| Scope 3 | - | - | - | - |
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Torrent Pharmaceuticals is not committed to any reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
